Select Language

Integrin α 4 β 7

Product Inquiry

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Mibavademab	REGN-4461	Phase 3 Clinical		Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Obesity; Lipid Metabolism Disorders	Details
ERX-1000	ERX-1000	Phase 1 Clinical	ERX Pharmaceuticals Inc	Obesity	Details

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Metreleptin	KTR-103; AC-164594	Approved	Amylin Pharmaceutical, Bristol-Myers Squibb Company, Astrazeneca Plc	Metreleptin [SHIONOGI], Myalepta	Japan	Lipodystrophy	Shionogi & Co Ltd	2013-03-25	HIV Infections; Diabetes Mellitus, Type 1; Metabolic Dysfunction-Associated Steatotic Liver Disease; Insulin Resistance; Metabolic Syndrome; Lipodystrophy; Obesity; Lipodystrophy, Congenital Generalized; Lipodystrophy, Familial Partial; Lipomatosis, Multiple Symmetrical; Overweight; Diabetes Mellitus; Hyperlipidemias	Details